Company intelligence / Profile preview

MedTecX

Ownership: Private
Development stage: Commercial

Overview

MedTecX develops and accelerates access to advanced medical device platforms—including high precision catheters, neuro-modulation systems, next-generation energy ablation tools, and implantable devices—primarily targeting the Chinese market. The company acts as both a developer of proprietary technologies and an accelerator for global medtech innovation entering China. Clinical results are not detailed publicly; focus is on commercialization rather than drug clinical trials.

Therapeutic areas: CardiovascularNeurology
Modalities: DeviceImplantable deviceEnergy ablation technologyNeuro-modulation technology
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on MedTecX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedTecX.

Explore the full profile